Literature DB >> 16330931

The diagnostic value of beta-catenin immunohistochemistry.

Elizabeth Montgomery1, Andrew L Folpe.   

Abstract

beta-catenin is a 92-kDa protein that binds to the cytoplasmic tail of E-cadherin. It acts in the nucleus to stimulate cell proliferation and is degraded by complexing with the adenomatous polyposis coli gene. When it is mutated, it is ineffectively degraded and results in unchecked proliferative activity that plays a role in a subset of neoplasms. When there are alterations in beta-catenin degradation, it accumulates to a sufficient extent to be detected in the nuclei of tumor cells immunohistochemically, a feature that can be exploited in the differential diagnosis of selected neoplasms. Immunohistochemistry for beta-catenin may be useful in the differential diagnosis of selected tumors of soft tissue, the gastrointestinal tract, including the pancreas, lung, and female genital tract.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330931     DOI: 10.1097/01.pap.0000194628.58501.71

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  11 in total

Review 1.  Desmoplastic fibroma of the mandible: a series of three cases and review of literature.

Authors:  T R Woods; D M Cohen; M N Islam; Y Rawal; I Bhattacharyya
Journal:  Head Neck Pathol       Date:  2014-08-12

2.  Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.

Authors:  Rujue Jin; Weigang Zhu; Jiajun Xu; Jianhui Gu; Aidong Deng
Journal:  Gene Ther       Date:  2022-03-28       Impact factor: 5.250

3.  Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.

Authors:  Ilse Degreef; Luc De Smet; Raf Sciot; Jean-Jacques Cassiman; Sabine Tejpar
Journal:  Clin Orthop Relat Res       Date:  2008-10-29       Impact factor: 4.176

4.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

Authors:  Alexander J F Lazar; Daniel Tuvin; Shohrae Hajibashi; Sultan Habeeb; Svetlana Bolshakov; Empar Mayordomo-Aranda; Carla L Warneke; Dolores Lopez-Terrada; Raphael E Pollock; Dina Lev
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

5.  Epithelial-Mesenchymal Transition Protein Expression in Basal Cell Adenomas and Basal Cell Adenocarcinomas.

Authors:  Brennan A Tesdahl; Thomas C Wilson; Henry T Hoffman; Robert A Robinson
Journal:  Head Neck Pathol       Date:  2015-10-06

6.  Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.

Authors:  Lars Olsen; Benito Campos; Ole Winther; Dennis C Sgroi; Barry L Karger; Vladimir Brusic
Journal:  BMC Med Genomics       Date:  2014-12-08       Impact factor: 3.063

7.  Diagnostic and therapeutic dilemmas in intra-abdominal desmoid tumors: A case report and literature review.

Authors:  Austin D Williams; Kimberly Heightchew; Veeraiah Siripirapu
Journal:  Int J Surg Case Rep       Date:  2016-07-28

8.  Pathology of gastrointestinal stromal tumors.

Authors:  Wai Chin Foo; Bernadette Liegl-Atzwanger; Alexander J Lazar
Journal:  Clin Med Insights Pathol       Date:  2012-07-17

9.  Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.

Authors:  Evert-Jan P M Ten Dam; Marike M van Beuge; Ruud A Bank; Paul M N Werker
Journal:  J Cell Commun Signal       Date:  2015-12-03       Impact factor: 5.782

10.  Clinical significance of midkine expression in sporadic desmoid tumors.

Authors:  Hee Sung Kim; Jin Kim; Kyung Han Nam; Woo Ho Kim
Journal:  Oncol Lett       Date:  2016-01-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.